| Value | ₹0.01 Cr |
|---|
NSE filing, NSE: UTSSAV. Summary written from the filing by ALFA Finder's alert engine.
Utssav CZ Gold Jewels Ltd: key numbers
- Share price
- ₹938.20
- Market cap
- ₹2,235 Cr
- Revenue (annual)
- ₹1,155 Cr
- Net profit (annual)
- ₹59.06 Cr
- P/E (TTM)
- 37.8×Sector 49.0×
- Promoter holding
- 72.55%
- FII holding
- 0.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Utssav CZ Gold Jewels Ltd
All →Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels approved a 1:1 bonus issue of 2,49,98,000 shares, subject to shareholder approval. No cash is paid; the shares come from free reserves.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels scheduled a board meeting for 23 October 2026 to consider a bonus issue and capital increase. No ratio or details disclosed yet.
Utssav CZ Gold Jewels Capacity Expansion: ₹10 Cr Investment
Utssav CZ Gold Jewels Limited has approved a capacity expansion at its jewellery manufacturing facility with an investment of Rs. 10 Crore. The expansion adds 2,000 kg per annum capacity.
- Value
- ₹10.00 Cr
- Execution
- FY 2026-27
- gold jewellery manufacturing capacity
- 2000.0 kg per annum
Utssav CZ Gold Jewels Annual General Meeting
The company held its 19th Annual General Meeting on September 24, 2026, via video conference. Members considered financial adoption and the re-appointment of a director.
Utssav CZ Gold Jewels Price Movement Clarification
Utssav CZ Gold Jewels clarified to the Exchange that recent share price movements are market-driven and not due to any undisclosed price-sensitive information.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr